Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Hamilton

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Clinical Therapeutics|February 29, 2016
Cost-effectiveness of Apixaban Versus Other Oral Anticoagulants for the Initial Treatment of Venous Thromboembolism and Prevention of RecurrenceTereza Lanitis, Robert Leipold, Melissa Hamilton, et al.
Pharmacoeconomics - Open|August 25, 2022
Cost-Utility of Nivolumab Plus Ipilimumab in First-Line Treatment of Advanced Melanoma in the United States: An Analysis Using Long-Term Overall Survival Data from Checkmate 067Timothy Baker, Helen Johnson, Srividya Kotapati, et al.
Heart, Lung & Circulation|May 20, 2014
Seven years experience of a nurse-led elective cardioversion service in a tertiary referral centre: an observational studyPeter T Moore, Gerald C Kaye, Melissa Hamilton, et al.
Stroke|April 28, 2017
Ischemic Stroke in Nonvalvular Atrial Fibrillation at Warfarin Initiation: Assessment via a Large Insurance DatabasePing G Tepper, Xianchen Liu, Melissa Hamilton, et al.
Thrombosis and Haemostasis|August 20, 2016
Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin. A propensity score matched analysisGregory Y H Lip, Allison Keshishian, Shital Kamble, et al.
Future Oncology (London, England)|February 7, 2022
Treatment patterns and outcomes following disease progression on anti-PD-1 therapies for advanced melanomaBeth L Nordstrom, Melissa Hamilton, Jenna M Collins, et al.
Current Medical Research and Opinion|September 26, 2017
Outcomes associated with warfarin time in therapeutic range among US veterans with nonvalvular atrial fibrillationShuqian Liu, Xiaoyan Li, Qian Shi, et al.
American Journal of Therapeutics|March 8, 2013
Venous thromboembolism prophylaxis and clinical consequences in medically ill patientsOnur Baser, Xianchen Liu, Hemant Phatak, et al.
The Oncologist|January 27, 2024
The Relationship Between Health-Related Quality of Life and Overall Survival in Patients With Advanced Renal Cell Carcinoma in CheckMate 214David Cella, Toni K Choueiri, Melissa Hamilton, et al.
The Journal of Surgical Research|December 12, 2018
The Potential Dangers of Recruitment Maneuvers During One Lung Ventilation SurgeryBiniam Kidane, Daniel Cornejo Palma, Neal H Badner, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Clinical Therapeutics|February 29, 2016
Cost-effectiveness of Apixaban Versus Other Oral Anticoagulants for the Initial Treatment of Venous Thromboembolism and Prevention of RecurrenceTereza Lanitis, Robert Leipold, Melissa Hamilton, et al.
Pharmacoeconomics - Open|August 25, 2022
Cost-Utility of Nivolumab Plus Ipilimumab in First-Line Treatment of Advanced Melanoma in the United States: An Analysis Using Long-Term Overall Survival Data from Checkmate 067Timothy Baker, Helen Johnson, Srividya Kotapati, et al.
Heart, Lung & Circulation|May 20, 2014
Seven years experience of a nurse-led elective cardioversion service in a tertiary referral centre: an observational studyPeter T Moore, Gerald C Kaye, Melissa Hamilton, et al.
Stroke|April 28, 2017
Ischemic Stroke in Nonvalvular Atrial Fibrillation at Warfarin Initiation: Assessment via a Large Insurance DatabasePing G Tepper, Xianchen Liu, Melissa Hamilton, et al.
Thrombosis and Haemostasis|August 20, 2016
Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin. A propensity score matched analysisGregory Y H Lip, Allison Keshishian, Shital Kamble, et al.
Future Oncology (London, England)|February 7, 2022
Treatment patterns and outcomes following disease progression on anti-PD-1 therapies for advanced melanomaBeth L Nordstrom, Melissa Hamilton, Jenna M Collins, et al.
Current Medical Research and Opinion|September 26, 2017
Outcomes associated with warfarin time in therapeutic range among US veterans with nonvalvular atrial fibrillationShuqian Liu, Xiaoyan Li, Qian Shi, et al.
American Journal of Therapeutics|March 8, 2013
Venous thromboembolism prophylaxis and clinical consequences in medically ill patientsOnur Baser, Xianchen Liu, Hemant Phatak, et al.
The Oncologist|January 27, 2024
The Relationship Between Health-Related Quality of Life and Overall Survival in Patients With Advanced Renal Cell Carcinoma in CheckMate 214David Cella, Toni K Choueiri, Melissa Hamilton, et al.
The Journal of Surgical Research|December 12, 2018
The Potential Dangers of Recruitment Maneuvers During One Lung Ventilation SurgeryBiniam Kidane, Daniel Cornejo Palma, Neal H Badner, et al.
Pageof 4